[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
October 11, 2006

Stem Cell Research

JAMA. 2006;296(14):1720. doi:10.1001/jama.296.14.1720-b

Sen Tom Harkin (D, Iowa) said Congress must overcome President Bush's July veto of HR 810, the Stem Cell Research Enhancement Act, which would make available multiple stem cell lines permissible for use in federally funded medical research.

Harkin's comments came during a September 6 Senate Appropriations Subcommittee on Labor, Health and Human Services and Education hearing on controversies surrounding stem cell research. At center stage was testimony surrounding Advanced Cell Technology (ACT) Inc of Worcester, Mass, and its findings published online ahead of print in Nature (Klimanskaya I et al. Nature. August 23, 2006. doi: 10.1038/nature05142) describing a technique for developing stem cell lines from individual blastomeres without destroying the embryo.